Metraipolis › archive › dc_aefb042958cc
Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes — Europe PMC PMID:42211875
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42211875
- DOI
- 10.1016/j.jacig.2026.100728
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T02:33:23.328Z
- SHA-256 of the archived text
e29344bffefa2fe2e2a61508cd8c67a6c00721c37f943fc653e6b3db7117cb28- Stable URL of this page
https://metraipolis.com/documento/dc_aefb042958cc
How to cite
Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes — Europe PMC PMID:42211875 — Europe PMC (en), https://europepmc.org/article/MED/42211875 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aefb042958cc (Metraipolis archive dc_aefb042958cc, sha256 e29344bffefa2fe2e2a61508cd8c67a6c00721c37f943fc653e6b3db7117cb28)
BibTeX
@misc{dcaefb042958cc,
title = {Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes — Europe PMC PMID:42211875},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42211875},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aefb042958cc; sha256 e29344bffefa2fe2e2a61508cd8c67a6c00721c37f943fc653e6b3db7117cb28},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211875. Agents can read the archived copy with the MCP tool read_document.